Story perspectives

HHS Draft Policy Lets Compounding Pharmacies Make 6 Peptides

By Drooid · Oct 29, 2026 · How we work

Read the story

Story summary

Summary

U.S. Health and Human Services issued a draft policy permitting compounding pharmacies to prepare six unapproved peptide drugs.
The policy directs the FDA not to enforce actions against licensed pharmacies that compound the six peptides.
The six peptides are BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500, none of which have FDA approval.
An HHS-chosen advisory panel voted in July to recommend the policy despite opposition from FDA scientists.

1 of 1

U.S. Health and Human Services issued a draft policy permitting compounding pharmacies to prepare six unapproved peptide drugs.
The policy directs the FDA not to enforce actions against licensed pharmacies that compound the six peptides.
The six peptides are BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500, none of which have FDA approval.
An HHS-chosen advisory panel voted in July to recommend the policy despite opposition from FDA scientists.